U.S. markets open in 2 hours 54 minutes
  • S&P Futures

    4,042.75
    -16.00 (-0.39%)
     
  • Dow Futures

    33,303.00
    -205.00 (-0.61%)
     
  • Nasdaq Futures

    12,958.25
    -40.25 (-0.31%)
     
  • Russell 2000 Futures

    2,121.30
    -10.20 (-0.48%)
     
  • Crude Oil

    64.17
    -1.91 (-2.89%)
     
  • Gold

    1,810.40
    -12.40 (-0.68%)
     
  • Silver

    26.82
    -0.42 (-1.56%)
     
  • EUR/USD

    1.2073
    -0.0003 (-0.02%)
     
  • 10-Yr Bond

    1.6950
    0.0000 (0.00%)
     
  • Vix

    27.74
    +5.90 (+27.01%)
     
  • GBP/USD

    1.4017
    -0.0040 (-0.28%)
     
  • USD/JPY

    109.6700
    +0.0100 (+0.01%)
     
  • BTC-USD

    49,365.91
    -6,962.51 (-12.36%)
     
  • CMC Crypto 200

    1,325.77
    -238.07 (-15.22%)
     
  • FTSE 100

    6,860.53
    -144.10 (-2.06%)
     
  • Nikkei 225

    27,448.01
    -699.50 (-2.49%)
     

TransMedics: Q4 Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

ANDOVER, Mass. (AP) _ TransMedics Group Inc. (TMDX) on Tuesday reported a loss of $6.3 million in its fourth quarter.

The Andover, Massachusetts-based company said it had a loss of 23 cents per share.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The medical technology company posted revenue of $7.6 million in the period.

For the year, the company reported that its loss narrowed to $28.7 million, or $1.16 per share. Revenue was reported as $25.6 million.

TransMedics shares have risen 99% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $39.69, more than doubling in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TMDX at https://www.zacks.com/ap/TMDX